Table 6 Genotype frequencies of four polymorphisms in ONFH patients in the relation to gender (total, female and male) and controls
Genotype | Controls N=100 | Patients | ||
|---|---|---|---|---|
Total N=68 | Female n=12 | Male n=56 | ||
Factor V Leiden | ||||
GA | 3(3%) | 3(4,41%) | 0 | 3(5,66%) |
GG | 97(97%) | 65(95,59%) | 12(100%) | 53(94,34%) |
Prothrombin | ||||
GA | 2(2%) | 1(1,47%) | 0 | 1(1,78%) |
GG | 98(98%) | 67(98,53%) | 12(100%) | 55(98,22%) |
MTHFR | ||||
TT | 7(7%) | 4(5,88%) | 2(18,66%) | 2(3,57%) |
CT | 42(42%) | 35(51,47%) | 7(56,34%) | 28(50,01%) |
CC | 51(51%) | 29(42,65%) | 3(25%) | 26(46,42%) |
TPA | ||||
DD | 18(18%) | 13(19,12%) | 2(16,66%) | 11(19,64%) |
ID | 37(37%) | 38(55,88%)a | 4(33,34%) | 34(60,72%)b |
II | 45(45%) | 17(25%) | 6(50,0%) | 11(19,64%) |